Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2010
08/12/2010CA2751536A1 Indoline derivatives
08/12/2010CA2751535A1 Substituted spiro-amides as b1r modulators
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2750714A1 Dihydroquinolinone derivatives
08/12/2010CA2750324A1 Hydrazide compound and use of the same in pest control
08/12/2010CA2749837A1 Derivatives of n2-(3-pyridil or phenyl) -n4- (4-piperidyl) -2,4- pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
08/12/2010CA2749358A1 A novel cyanopyrimidine derivative
08/12/2010CA2749209A1 Indole derivatives as anticancer agents
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2216333A2 Crystalline forms of Dexlansoprazole
08/11/2010EP2215081A2 Processes and intermediates for producing aminobenzimidazole ureas
08/11/2010EP2215080A1 Diazepane compounds which modulate the cb2 receptor
08/11/2010EP2215079A1 Inhibitors of c-fms kinase
08/11/2010EP2215078A1 Azetidinyl g-protein coupled receptor agonists
08/11/2010EP2215077A1 Azetidinyl g-protein coupled receptor agonists
08/11/2010EP2215076A2 Compounds that inhibit protease cathepsin s and hcv replication
08/11/2010EP2215074A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
08/11/2010EP2215073A1 Modulation of sleep with nr2b receptor antagonists
08/11/2010EP2215067A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
08/11/2010EP2215066A1 Amide derivatives as sirtuin modulators
08/11/2010EP2215055A1 New non-peptide derivatives as bradykinin b1 antagonists
08/11/2010EP2215052A1 Desferrioxamine conjugates, derivatives and analogues
08/11/2010EP2215049A1 P2x3, receptor antagonists for treatment of pain
08/11/2010EP2214669A1 Cytokine inhibitors
08/11/2010EP2214667A2 Small molecule inhibitors of parp activity
08/11/2010EP2214487A1 Novel seh inhibitors and their use
08/11/2010EP2214486A1 Heteroaryl compounds and uses thereof
08/11/2010EP2099763B1 2-aminoquinolines as 5-ht(5a) receptor antagonists
08/11/2010EP1871760B1 Cyano anthranilamide insecticides
08/11/2010EP1809605B1 Quinolines as allosteric enhancers of the gaba-b receptors
08/11/2010EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3
08/11/2010EP1487763B1 Use of microfabricated devices for radiosynthesis
08/11/2010EP1484301B1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
08/11/2010EP1263731B1 Method for producing 5-aryl nicotinaldehydes
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN1997649B Inhibitors of histone deacetylase
08/11/2010CN101801958A Heterocyclic amide compounds as protein kinase inhibitors
08/11/2010CN101801957A pyridone gpr119 g protein-coupled receptor agonists
08/11/2010CN101801956A Method for modulating GPR119 G protein-coupled receptor and selected compounds
08/11/2010CN101801955A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/11/2010CN101801954A Compounds and compositions as modulators of GPR119 activity
08/11/2010CN101801953A Tetrahydropyridine carboxamide derivatives as TRPVl antagonists
08/11/2010CN101801952A N-heterocyclic biaryl carboxamides as ccr receptor antagonists
08/11/2010CN101801951A 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
08/11/2010CN101801950A Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
08/11/2010CN101801938A non-basic melanin concentrating hormone receptor-1 antagonists and methods
08/11/2010CN101801935A uracil or thymine derivative for treating hepatitis c
08/11/2010CN101801934A 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/11/2010CN101801932A Substituted nicotinamide compounds and the use thereof in pharmaceutical products
08/11/2010CN101801931A Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
08/11/2010CN101801927A Piperidine derivatives as nk3 receptor antagonists
08/11/2010CN101801925A antiviral compounds
08/11/2010CN101801383A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/11/2010CN101798299A Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101098867B Substituted sulfoxide compound and its preparing method and application
08/11/2010CN101039930B 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt
08/10/2010US7772432 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide
08/10/2010US7772254 Pyridylene compounds used as analgesics and for inhibiting Vanilloid Receptor 1 and metabotropic glutamate receptor 1 function in a cells
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772247 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) receptor antagonists such as 1-(4-(2-(N-methoxy-N-methylcarbamoyl)thieno[3,2-b]pyridin-7yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea, used as antiproliferative agents
08/10/2010US7772244 Therapeutic agents for the treatment of migraine
08/10/2010US7772243 such as -Piperidin-1-yl-but-2-enoic acid [4(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yl]-amide, used as tyrosine kinase inhibitors, for the prevention of proliferative diseases, including cancer, atherosclerosis, restenosis, endometriosis and psoriasis
08/10/2010US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches
08/10/2010US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds
08/10/2010CA2527315C Imidazole derivatives as glutamate receptor antagonists
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2462694C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
08/10/2010CA2462132C 1,2,4-triazole compounds
08/10/2010CA2451605C Diamine derivatives
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2334399C Uracil compounds and use thereof
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010088392A1 Carboxamide compounds and methods for using the same
08/05/2010WO2010087471A1 Hydroxypyrazinecarboxamide derivatives
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010086646A1 Scriptaid isosteres and their use in therapy
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086366A1 4-aryl-butane-1,3-diamides
08/05/2010WO2010086259A1 Piperidine derivatives as nk3 receptor antagonists
08/05/2010WO2010086251A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010WO2010042867A3 Activators of human pyruvate kinase
08/05/2010WO2010031056A3 Methods and compositions for modulating ire1, src, and abl activity
08/05/2010WO2010023512A8 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010US20100197925 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197909 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in subtituent at 14-position
08/05/2010US20100197908 Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds
08/05/2010US20100197871 Ligands for copper-catalyzed azide-alkyne cycloaddition reactions
08/05/2010US20100197749 Chemical compounds
08/05/2010US20100197736 Cetp activity inhibitors
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1080